Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Efficacy, safety and effectiveness of licensed rotavirus vaccines: a systematic review and meta-analysis for Latin America and the Caribbean.

Velázquez RF, Linhares AC, Muñoz S, Seron P, Lorca P, DeAntonio R, Ortega-Barria E.

BMC Pediatr. 2017 Jan 13;17(1):14. doi: 10.1186/s12887-016-0771-y.

2.

Effectiveness of rotavirus vaccines against rotavirus infection and hospitalization in Latin America: systematic review and meta-analysis.

Santos VS, Marques DP, Martins-Filho PR, Cuevas LE, Gurgel RQ.

Infect Dis Poverty. 2016 Aug 12;5(1):83. doi: 10.1186/s40249-016-0173-2. Review.

3.

ROTAVIRUS GENOTYPES CIRCULATING IN BRAZIL, 2007-2012: IMPLICATIONS FOR THE VACCINE PROGRAM.

Luchs A, Cilli A, Morillo SG, Carmona Rde C, Timenetsky Mdo C.

Rev Inst Med Trop Sao Paulo. 2015 Jul-Aug;57(4):305-13. doi: 10.1590/S0036-46652015000400006.

4.

Incidence of rotavirus and circulating genotypes in Northeast Brazil during 7 years of national rotavirus vaccination.

Gurgel RQ, Alvarez Ade J, Rodrigues A, Ribeiro RR, Dolabella SS, Da Mota NL, Santos VS, Iturriza-Gomara M, Cunliffe NA, Cuevas LE.

PLoS One. 2014 Oct 31;9(10):e110217. doi: 10.1371/journal.pone.0110217.

5.

Genetic diversity of G3 rotavirus strains circulating in Argentina during 1998-2012 assessed by full genome analyses.

Degiuseppe JI, Parra GI, Stupka JA.

PLoS One. 2014 Oct 22;9(10):e110341. doi: 10.1371/journal.pone.0110341.

6.

Detection of enteric viruses in activated sludge by feasible concentration methods.

Prado T, Gaspar AM, Miagostovich MP.

Braz J Microbiol. 2014 May 19;45(1):343-9.

7.

Rotavirus G9P[4] in 3 countries in Latin America, 2009-2010.

Quaye O, McDonald S, Esona MD, Lyde FC, Mijatovic-Rustempasic S, Roy S, Banegas DJ, Quiñonez YM, Chinchilla BL, Santiago FG, Lozano HG, Rey-Benito G, de Oliveira LH, Gentsch JR, Bowen MD.

Emerg Infect Dis. 2013 Aug;19(8):1332-3. doi: 10.3201/eid1908.130288. No abstract available.

8.

Recombinant monovalent llama-derived antibody fragments (VHH) to rotavirus VP6 protect neonatal gnotobiotic piglets against human rotavirus-induced diarrhea.

Vega CG, Bok M, Vlasova AN, Chattha KS, Gómez-Sebastián S, Nuñez C, Alvarado C, Lasa R, Escribano JM, Garaicoechea LL, Fernandez F, Bok K, Wigdorovitz A, Saif LJ, Parreño V.

PLoS Pathog. 2013;9(5):e1003334. doi: 10.1371/journal.ppat.1003334.

9.

Burden and typing of rotavirus group a in children with acute gastroenteritis in shiraz, southern iran.

Najafi A, Kargar M, Jafarpour T.

Iran Red Crescent Med J. 2012 Sep;14(9):531-40. Erratum in: Iran Red Crescent Med J. 2013 Feb;15(2):175. Najafi, A [corrected to Najafi, Akram]; Kargar, M [corrected to Kargar, Mohammad]; Jafarpour, T [corrected to Jafarpour, Tarlan].

10.
11.

In vitro neutralisation of rotavirus infection by two broadly specific recombinant monovalent llama-derived antibody fragments.

Aladin F, Einerhand AW, Bouma J, Bezemer S, Hermans P, Wolvers D, Bellamy K, Frenken LG, Gray J, Iturriza-Gómara M.

PLoS One. 2012;7(3):e32949. doi: 10.1371/journal.pone.0032949.

12.

Rotavirus vaccines: update on global impact and future priorities.

Yen C, Tate JE, Patel MM, Cortese MM, Lopman B, Fleming J, Lewis K, Jiang B, Gentsch J, Steele D, Parashar UD.

Hum Vaccin. 2011 Dec;7(12):1282-90. doi: 10.4161/hv.7.12.18321. Review.

Items per page

Supplemental Content

Support Center